An Open Label, Multicenter, First-in-Human, Dose-Escalation Phase I Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Phone: (800) 411-7999
An Open Label, Multicenter, First-in-Human, Dose-Escalation Phase I Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas